301 related articles for article (PubMed ID: 20048433)
1. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
[TBL] [Abstract][Full Text] [Related]
2. [Idiopathic hyperuricemia with overproduction of uric acid].
Mizuta E; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):675-8. PubMed ID: 18409513
[TBL] [Abstract][Full Text] [Related]
3. Uric acid: role in cardiovascular disease and effects of losartan.
Alderman M; Aiyer KJ
Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
[TBL] [Abstract][Full Text] [Related]
4. Altered uric acid levels and disease states.
Kutzing MK; Firestein BL
J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
[TBL] [Abstract][Full Text] [Related]
5. Medical implications of hyperuricemia.
Sachs L; Batra KL; Zimmermann B
Med Health R I; 2009 Nov; 92(11):353-5. PubMed ID: 19999892
[No Abstract] [Full Text] [Related]
6. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
7. [Is hyperuricemia a cardiovascular risk factor?].
Chizyński K; Rózycka M
Wiad Lek; 2006; 59(5-6):364-7. PubMed ID: 17017483
[TBL] [Abstract][Full Text] [Related]
8. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
9. [Uric acid--more deleterious than we thought?].
Høieggen A; Os I; Kjeldsen SE
Tidsskr Nor Laegeforen; 2005 May; 125(10):1330-2. PubMed ID: 15909004
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
Baker JF; Schumacher HR; Krishnan E
Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
[TBL] [Abstract][Full Text] [Related]
11. Status of uric acid management in hypertensive subjects.
Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
[TBL] [Abstract][Full Text] [Related]
12. [Hyperuricemia].
Chizyński K; Rózycka M
Pol Merkur Lekarski; 2005 Nov; 19(113):693-6. PubMed ID: 16498814
[TBL] [Abstract][Full Text] [Related]
13. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
Lin KC; Tsao HM; Chen CH; Chou P
J Rheumatol; 2004 Jun; 31(6):1152-8. PubMed ID: 15170929
[TBL] [Abstract][Full Text] [Related]
14. Uric acid and oxidative stress: relative impact on cardiovascular risk?
Strazzullo P; Puig JG
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
[TBL] [Abstract][Full Text] [Related]
15. [Hyperuricemia in hypertension: any clinical implication?].
Deléaval P; Burnier M
Rev Med Suisse; 2005 Sep; 1(32):2072-4, 2077-9. PubMed ID: 16238227
[TBL] [Abstract][Full Text] [Related]
16. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
17. Uric acid and the development of hypertension.
Hwu CM; Lin KH
Med Sci Monit; 2010 Oct; 16(10):RA224-30. PubMed ID: 20885365
[TBL] [Abstract][Full Text] [Related]
18. Effects of cilnidipine on serum uric acid level and urinary nitrogen monoxide excretion in patients with hypertension.
Hamada T; Yamada K; Mizuta E; Watanabe A; Osaki T; Ishida K; Hasegawa A; Sakata S; Mishima M; Ogino K; Nosaka Y; Miyazaki S; Ohtahara A; Ninomiya H; Kato M; Yoshida A; Taniguchi S; Yamamoto K; Hisatome I
Clin Exp Hypertens; 2012; 34(7):470-3. PubMed ID: 22681507
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid: a risk factor and a target for treatment?
Feig DI; Mazzali M; Kang DH; Nakagawa T; Price K; Kannelis J; Johnson RJ
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S69-73. PubMed ID: 16565251
[TBL] [Abstract][Full Text] [Related]
20. [Hypertension and hyperuricemia].
Hirai A; Saitoh Y
Nihon Rinsho; 1996 Dec; 54(12):3283-8. PubMed ID: 8976106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
